Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Oosterwijk

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997
Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody primingM H Kranenborg, W J Oyen, F H Corstens, et al.
International Journal of Cancer|January 14, 1998
Two-step radio-immunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal-cell-carcinoma X anti-DTPA bispecific monoclonal antibodiesM H Kranenborg, O C Boerman, J C Oosterwijk-Wakka, et al.
Cancer|December 24, 1997
The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenograftsM H Kranenborg, O C Boerman, M C de Weijert, et al.
Cancer Research|December 1, 1995
Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinomaM H Kranenborg, O C Boerman, J C Oosterwijk-Wakka, et al.
International Journal of Cancer|November 14, 1997
Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinomaT Shimazui, P P Bringuier, H van Berkel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 1999
In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparationsM G Steffens, E Oosterwijk, M H Kranenborg, et al.
European Urology|August 15, 2000
Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinomaT Shimazui, J Oosterwijk-Wakka, H Akaza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1988
Perfusion of tumor-bearing kidneys as a model for scintigraphic screening of monoclonal antibodiesJ van Dijk, E Oosterwijk, M J van Kroonenburgh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 3, 2011
Lyophilisomes: Potential carriers for tumor targetingE van Bracht, P J Geutjes, R Woestenenk, et al.
Anticancer Research|August 23, 2000
Flow cytometric analysis of antigen expression in malignant and normal renal cellsG Li, K Passebosc-Faure, C Lambert, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997
Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody primingM H Kranenborg, W J Oyen, F H Corstens, et al.
International Journal of Cancer|January 14, 1998
Two-step radio-immunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal-cell-carcinoma X anti-DTPA bispecific monoclonal antibodiesM H Kranenborg, O C Boerman, J C Oosterwijk-Wakka, et al.
Cancer|December 24, 1997
The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenograftsM H Kranenborg, O C Boerman, M C de Weijert, et al.
Cancer Research|December 1, 1995
Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinomaM H Kranenborg, O C Boerman, J C Oosterwijk-Wakka, et al.
International Journal of Cancer|November 14, 1997
Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinomaT Shimazui, P P Bringuier, H van Berkel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 1999
In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparationsM G Steffens, E Oosterwijk, M H Kranenborg, et al.
European Urology|August 15, 2000
Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinomaT Shimazui, J Oosterwijk-Wakka, H Akaza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1988
Perfusion of tumor-bearing kidneys as a model for scintigraphic screening of monoclonal antibodiesJ van Dijk, E Oosterwijk, M J van Kroonenburgh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 3, 2011
Lyophilisomes: Potential carriers for tumor targetingE van Bracht, P J Geutjes, R Woestenenk, et al.
Anticancer Research|August 23, 2000
Flow cytometric analysis of antigen expression in malignant and normal renal cellsG Li, K Passebosc-Faure, C Lambert, et al.
Pageof 8